Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
ADHD
News
Attention-Deficit Drug Maker Shire Up 5% on Blow-Out Q4; Outlook in Line
Barron's
Adderall
ADHD
Shire
»
Login
or
register
to post comments
News
Facing Stunted Growth in ADHD Market, Shire Clicks on Twitter
BNET Pharma
ADHD
Shire
social media
twitter
Vyvanase
»
Login
or
register
to post comments
News
Australia Pulls Guidelines For ADHD Medicines
Pharmalot
ADHD
Australia
physicial payments
»
32 comments
News
Shire gets boost as FDA backs Vyvanse exclusivity
Reuters
ADHD
FDA
Shire
Vyvanase
»
1 comment
News
Addrenex Pharmaceuticals Files SNDA Submission For Clonicel To Treat ADHD
Medical News Today
Addrenex
ADHD
Clonicel
»
2 comments
News
Impax shipping generic of ADHD drug Adderall XR
Yahoo/AP
Adderall
ADHD
generics
Impax
Shire
»
Login
or
register
to post comments
News
Shire wins U.S. approval for Intuniv drug
Reuters
ADHD
FDA
Intuniv
Shire
»
Login
or
register
to post comments
News
Durect licenses ADHD drug to Orient Pharma
Yahoo/AP
ADHD
Durect Corporation
liscensing
Orient Pharma
»
2 comments
News
AstraZeneca to start Phase IIb study of AZD3480
Marketwatch
ADHD
AstraZeneca
drug trials
Targacept
»
Login
or
register
to post comments
News
Attention Drugs May Be Linked to Sudden Death in Kids
Bloomberg
Adderall XR
ADHD
Novartis
Ritalin
Shire
»
Login
or
register
to post comments
« first
‹ previous
1
2
3
4
5
6
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT